News
August 20, 2020
Eight teams of engineers and physicians work to tackle COVID-19 related challenges
The Galvanizing Engineering in Medicine program at UC San Diego is supporting eight COVID-19 related projects in early stages with microgrants. The program is a collaboration between the Altman Clinical and Translational Research Institute and the Institute of Engineering in Medicine launched in 2013 to bring engineers and clinicians together to develop innovative technologies and solve challenging problems in medical care. Full Story
August 17, 2020
UC San Diego named 4th best public research university in prestigious global rankings
Shanghai rankings celebrate campus as a world-renowned research powerhouse. Full Story
August 11, 2020
Flipping a metabolic switch to slow tumor growth
The enzyme serine palmitoyl-transferase can be used as a metabolically responsive “switch” that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug. 12 in the journal Nature. By restricting the dietary amino acids serine and glycine, or pharmacologically targeting the serine synthesis enzyme phosphoglycerate dehydrogenase, the team induced tumor cells to produce a toxic lipid that slows cancer progression in mice. Further research is needed to determine how this approach might be translated to patients. Full Story
Annual Reports
2025 Department Impact Report
- Undergraduate Instructional Lab Opening
- Faculty Recognition & Awards
- Research HIghlights
- Student & BE Community Highlights
Fact Sheet
